These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9153656)

  • 61. Lack of evidence for coupling of the dopamine D2 receptor to an adenosine triphosphate-sensitive potassium (ATP-K+) channel in dopaminergic neurones of the rat substantia nigra.
    Hicks GA; Henderson G
    Neurosci Lett; 1992 Jul; 141(2):213-7. PubMed ID: 1436636
    [TBL] [Abstract][Full Text] [Related]  

  • 62. D3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neurons.
    Davila V; Yan Z; Craciun LC; Logothetis D; Sulzer D
    J Neurosci; 2003 Jul; 23(13):5693-7. PubMed ID: 12843272
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors.
    Nimitvilai S; Arora DS; McElvain MA; Brodie MS
    Neuroscience; 2012 Dec; 226():29-39. PubMed ID: 22986166
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 1-Methyl-4-phenylpridinium (MPP+)-induced functional run-down of GABA(A) receptor-mediated currents in acutely dissociated dopaminergic neurons.
    Wu J; Chan P; Schroeder KM; Ellsworth K; Partridge LD
    J Neurochem; 2002 Oct; 83(1):87-99. PubMed ID: 12358732
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.
    Lindskog M; Svenningsson P; Fredholm BB; Greengard P; Fisone G
    Neuroscience; 1999; 88(4):1005-8. PubMed ID: 10336115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Indirect presynaptic modulation of striatal dopamine release by GABA(B) receptors in the rat substantia nigra.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurosci Lett; 2002 May; 325(1):33-6. PubMed ID: 12023061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Haloperidol activates tyrosine hydroxylase gene-expression in the rat substantia nigra, pars reticulata.
    Stork O; Hashimoto T; Obata K
    Brain Res; 1994 Jan; 633(1-2):213-22. PubMed ID: 7907932
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
    Thorré K; Sarre S; Smolders I; Ebinger G; Michotte Y
    Brain Res; 1998 Jun; 796(1-2):107-16. PubMed ID: 9689460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sex- and cell-type-specific patterns of GABAA receptor and estradiol-mediated signaling in the immature rat substantia nigra.
    Galanopoulou AS
    Eur J Neurosci; 2006 May; 23(9):2423-30. PubMed ID: 16706849
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--II. In vitro analysis.
    Nisenbaum ES; Grace AA; Berger TW
    Neuroscience; 1992; 48(3):579-93. PubMed ID: 1351271
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat.
    González-Hernández T; Rodríguez M
    J Comp Neurol; 2000 May; 421(1):107-35. PubMed ID: 10813775
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
    Kreiss DS; Bergstrom DA; Gonzalez AM; Huang KX; Sibley DR; Walters JR
    Eur J Pharmacol; 1995 Apr; 277(2-3):209-14. PubMed ID: 7493610
    [TBL] [Abstract][Full Text] [Related]  

  • 77. GABA axons in synaptic contact with dopamine neurons in the substantia nigra: double immunocytochemistry with biotin-peroxidase and protein A-colloidal gold.
    van den Pol AN; Smith AD; Powell JF
    Brain Res; 1985 Nov; 348(1):146-54. PubMed ID: 2866017
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: role of GABA receptors and GABA uptake.
    Chan PK; Yung WH
    Brain Res; 1999 Aug; 838(1-2):18-26. PubMed ID: 10446312
    [TBL] [Abstract][Full Text] [Related]  

  • 79. D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat.
    Cruz-Trujillo R; Avalos-Fuentes A; Rangel-Barajas C; Paz-Bermúdez F; Sierra A; Escartín-Perez E; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2013 Apr; 67():370-8. PubMed ID: 23238327
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Presynaptic modulation of the release of GABA by GABAA receptors in pars compacta and by GABAB receptors in pars reticulata of the rat substantia nigra.
    Floran B; Silva I; Nava C; Aceves J
    Eur J Pharmacol; 1988 Jun; 150(3):277-86. PubMed ID: 2843383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.